Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home News

How Precision Medicine Combats Underused Genomic Testing

I'm Online Chat Now
China Hangzhou AllTest Biotech CO.,LTD certification
China Hangzhou AllTest Biotech CO.,LTD certification
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

Company News
How Precision Medicine Combats Underused Genomic Testing
Latest company news about How Precision Medicine Combats Underused Genomic Testing

Medical oncologists need reliable and concise strategies to clarify therapeutic recommendations that consider patient-specific characteristics. Correlating somatic alterations to a patient’s clinical scenario is a time-consuming endeavor that requires continual updating to reflect the rapidly evolving information in the field of oncology. Contextualizing and sequencing somatic alteration interpretations with potential treatment options is prohibitively time-intensive for medical oncologists, a trend that will intensify even more as caseloads increase.

The presence of a medically focused precision medicine consultative service has shown proven value in the context of the current complexity and time constraints that medical oncologists face.

This approach will help medical oncologists reduce the amount of time spent interpreting somatic alterations and ensuring that interpretations are up to date with the most recent data relevant to individual cases. In turn, this will standardize and improve clinical care. The reporting from such a consultative service is also of high impact in letter of medical necessity discussions, where the goal is insurance company support for precision oncology options. By reducing the time burden spent per patient on result interpretation and therapeutic considerations, improved time efficiency may also strengthen revenue.



See More Detail About Tumor Markers Rapid Test: http://www.alltests.com.cn/

Pub Time : 2021-05-10 17:21:02 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: +86 13989889852

Fax: 86-571-56267856

Send your inquiry directly to us